RNECY vs. NVO
RNECY (Renesas Electronics Corp ADR) and NVO (Novo Nordisk A/S) are both stocks. RNECY operates in Semiconductors (Technology), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, RNECY returned 17.43%/yr vs 7.56%/yr for NVO. At a 0.11 correlation, their price movements are largely independent.
Performance
RNECY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RNECY achieves a 104.41% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, RNECY has outperformed NVO with an annualized return of 17.43%, while NVO has yielded a comparatively lower 7.56% annualized return.
RNECY
- 1D
- -0.64%
- 1M
- 13.19%
- YTD
- 104.41%
- 6M
- 104.71%
- 1Y
- 110.61%
- 3Y*
- 14.94%
- 5Y*
- 21.58%
- 10Y*
- 17.43%
NVO
- 1D
- -0.18%
- 1M
- -4.19%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -42.47%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
RNECY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RNECY Renesas Electronics Corp ADR | 104.41% | 7.51% | -28.20% | 103.64% | -29.19% | 18.55% | 52.92% | 53.71% | -60.76% | 43.54% |
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between RNECY and NVO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jul 13, 2007 | 0.11 |
Fundamentals
RNECY:
$51.26B
NVO:
$195.21B
RNECY:
-¥2.98
NVO:
DKK 27.42
RNECY:
5.56
NVO:
3.85
RNECY:
3.22
NVO:
6.21
RNECY:
¥1.46T
NVO:
DKK 327.80B
RNECY:
¥692.31B
NVO:
DKK 268.30B
RNECY:
¥475.96B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RNECY vs. NVO — Risk / Return Rank
RNECY
NVO
RNECY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Renesas Electronics Corp ADR (RNECY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RNECY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.64 | ||
| Sortino ratioReturn per unit of downside risk | +3.52 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 0.85 | +0.46 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | -0.80 | +4.15 |
| Martin ratioReturn relative to average drawdown | 9.43 | -1.18 | +10.61 |
Loading charts...
Drawdowns
RNECY vs. NVO - Drawdown Comparison
The maximum RNECY drawdown since its inception was -92.23%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for RNECY and NVO.
Loading charts...
Drawdown Indicators
| RNECY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.23% | -74.70% | -17.53% |
Max Drawdown (1Y)Largest decline over 1 year | -31.29% | -54.34% | +23.05% |
Max Drawdown (3Y)Largest decline over 3 years | -52.49% | -74.70% | +22.21% |
Max Drawdown (5Y)Largest decline over 5 years | -52.49% | -74.70% | +22.21% |
Max Drawdown (10Y)Largest decline over 10 years | -77.20% | -74.70% | -2.50% |
Current DrawdownCurrent decline from peak | -8.70% | -68.11% | +59.41% |
Average DrawdownAverage peak-to-trough decline | -67.21% | -17.79% | -49.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.48% | 37.62% | -26.14% |
Volatility
RNECY vs. NVO - Volatility Comparison
Renesas Electronics Corp ADR (RNECY) has a higher volatility of 26.88% compared to Novo Nordisk A/S (NVO) at 10.68%. This indicates that RNECY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RNECY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.88% | 10.68% | +16.20% |
Volatility (6M)Calculated over the trailing 6-month period | 47.53% | 38.04% | +9.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.05% | 51.88% | +6.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.74% | 38.33% | +9.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.47% | 32.56% | +16.91% |
Dividends
RNECY vs. NVO - Dividend Comparison
RNECY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
RNECY Renesas Electronics Corp ADR | 0.00% | 0.00% | 1.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RNECY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Renesas Electronics Corp ADR and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RNECY vs. NVO - Profitability Comparison
RNECY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Renesas Electronics Corp ADR reported a gross profit of 198.11B and revenue of 387.28B. Therefore, the gross margin over that period was 51.2%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
RNECY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Renesas Electronics Corp ADR reported an operating income of 93.16B and revenue of 387.28B, resulting in an operating margin of 24.1%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
RNECY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Renesas Electronics Corp ADR reported a net income of 69.40B and revenue of 387.28B, resulting in a net margin of 17.9%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
RNECY and NVO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RNECY has higher volatility (26.88%) compared to NVO (10.68%). In terms of maximum drawdown, RNECY dropped -92.23% vs NVO's -74.70%.
RNECY currently has the higher Sharpe Ratio (1.80 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RNECY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer